217 related articles for article (PubMed ID: 34162161)
1. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract][Full Text] [Related]
3. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
He L; Yang H; Huang J
BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
[TBL] [Abstract][Full Text] [Related]
4. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
6. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
7. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
8. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
[TBL] [Abstract][Full Text] [Related]
9. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
11. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
14. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
[TBL] [Abstract][Full Text] [Related]
15. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
16. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
Wang Q; Zhang W; Guo Y; Li Y; Fu K
Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.
Song YJ; Xu Y; Deng C; Zhu X; Fu J; Chen H; Lu J; Xu H; Song G; Tang Q; Wang J
Front Immunol; 2021; 12():623762. PubMed ID: 33959121
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
19. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Liu W; Xie X; Qi Y; Wu J
JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
[TBL] [Abstract][Full Text] [Related]
20. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
